|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Century Therapeutics (NASDAQ: IPSC) through any online brokerage.
The latest price target for Century Therapeutics (NASDAQ: IPSC) was reported by B of A Securities on July 13, 2021. The analyst firm set a price target for 34.00 expecting IPSC to rise to within 12 months (a possible 59.55% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Century Therapeutics (NASDAQ: IPSC) is $21.31 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Century Therapeutics.
Century Therapeutics’s $Q3 earnings are confirmed for after-market on $November 23, 2021.
There is no upcoming split for Century Therapeutics.
Century Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.